학술논문
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
Document Type
Article
Author
Sydes, M.R.; Spears, M.R.; Mason, M.D.; Clarke, N.W.; Dearnaley, D.P.; de Bono, J.S.; Attard, G.; Chowdhury, S.; Cross, W.; Gillessen, S.; Malik, Z.I.; Jones, R.; Parker, C.C.; Ritchie, A.W.S.; Russell, J.M.; Millman, R.; Matheson, D.; Amos, C.; Gilson, C.; Birtle, A.; Brock, S.; Capaldi, L.; Chakraborti, P.; Choudhury, A.; Evans, L.; Ford, D.; Gale, J.; Gibbs, S.; Gilbert, D.C.; Hughes, R.; McLaren, D.; Lester, J.F.; Nikapota, A.; O’Sullivan, J.; Parikh, O.; Peedell, C.; Protheroe, A.; Rudman, S.M.; Shaffer, R.; Sheehan, D.; Simms, M.; Srihari, N.; Strebel, R.; Sundar, S.; Tolan, S.; Tsang, D.; Varughese, M.; Wagstaff, J.; Parmar, M.K.B. ; James, N.D.
Source
In Annals of Oncology May 2018 29(5):1235-1248
Subject
Language
ISSN
0923-7534